10 domestic pharmaceutical companies won against the patent nullity trial of ‘Crestor’

10 domestic pharmaceutical companies won on the composite patent nullity trial of the hyperlipidemia treatment ‘Crestor’.

Thus, they have set a stable foundation to sell generic products of Crestor, which launched on the last April.

According to the pharmaceutical industry on the 26^th, the Intellectual Property Tribunal judged that the patent nullity request of the ‘Pharmaceutical Composite’ ...